Taner Basturk
Overview
Explore the profile of Taner Basturk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
548
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mirioglu S, Cebeci E, Yazici H, Derici U, Sahin G, Coban G, et al.
Clin Kidney J
. 2024 Oct;
17(8):sfae077.
PMID: 39421234
Background: Data on the prognostic factors for C3 glomerulopathy (C3G) are limited, and validation of the new C3G histologic index (C3G-HI) in different settings is still needed. We aimed to...
2.
Artan A, Mirioglu S, Hocaoglu R, Turgutalp K, Gullulu Boz S, Eren N, et al.
BMC Nephrol
. 2024 Oct;
25(1):327.
PMID: 39354386
Background: We evaluated the efficacy of different immunosuppressive regimens in patients with primary membranous nephropathy in a large national cohort. Methods: In this registry study, 558 patients from 47 centers...
3.
Hasbal N, Sevinc M, Yilmaz V, Yilmaz A, Korkmaz H, Basturk T, et al.
Blood Purif
. 2024 Sep;
53(11-12):937-946.
PMID: 39217984
Introduction: Chronic kidney disease (CKD) poses a significant global health burden, with increasing prevalence and high morbidity and mortality rates, particularly in end-stage kidney disease (ESKD). While traditional risk factors...
4.
Oruc A, Sumnu A, Turkmen A, Basturk T, Cebeci E, Turgutalp K, et al.
Ren Fail
. 2024 Apr;
46(1):2341787.
PMID: 38637275
Background: Immunoglobulin A (IgA) nephropathy (IgAN) treatment consists of maximal supportive care and, for high-risk individuals, immunosuppressive treatment (IST). There are conflicting results regarding IST. Therefore, we aimed to investigate...
5.
Sakaci T, Ahbap E, Basturk T, Ortaboz M, Ozagari A, Mazi E, et al.
Clin Nephrol
. 2024 Mar;
101(5):207-221.
PMID: 38431824
Background: Diabetic nephropathy is one of the most common complications associated with diabetes. However, non-diabetic kidney disease has been reported in patients with type 2 diabetes at varying incidence rates....
6.
Cetinkaya H, Gursu M, Yazici H, Cebeci E, Eren N, Altiparmak M, et al.
J Nephrol
. 2023 Nov;
37(4):923-932.
PMID: 37947938
Background: Immunoglobulin A nephropathy (IgAN) is a common primary glomerulonephropathy. There is evidence that mesangial C3 deposition plays a role in the development of the disease. The aim of this...
7.
Ahbap E, Mazi E, Basturk T, Sakaci T, Aykent M, Unsal A
Clin Nephrol
. 2023 May;
100(1):19-26.
PMID: 37143370
Objectives: Non-infectious complications of peritoneal dialysis (NICPD) are common and could be an important cause of technical failure, especially in the early period of peritoneal dialysis (PD) initiation. NICPD are...
8.
Ahbap E, Hasbal N, Sevinc M, Basturk T, Sakaci T, Unsal A
Sisli Etfal Hastan Tıp Bul
. 2022 Oct;
56(3):414-420.
PMID: 36304227
Objectives: In addition to an increase in the prevalence of dialysis treatments for end-stage renal disease worldwide, the mortality rates among patients on maintenance hemodialysis remain higher than that of...
9.
Karadag S, Ozturk S, Arici M, Gorgulu N, Akcali E, Pembegul I, et al.
Int Urol Nephrol
. 2022 Aug;
55(2):399-408.
PMID: 35951255
Purpose: Coronavirus disease 2019 (COVID-19) has a higher mortality in the presence of chronic kidney disease (CKD). However, there has not been much research in the literature concerning the outcomes...
10.
Turgutalp K, Cebeci E, Turkmen A, Derici U, Seyahi N, Eren N, et al.
BMC Nephrol
. 2021 Oct;
22(1):352.
PMID: 34711174
Background: Galactose-deficient IgA1 (Gd-IgA1) has an increased tendency to form immunocomplexes with IgG in the serum, contributing to IgAN pathogenesis by accumulating in the glomerular mesangium. Several studies showed that...